Om Megashree Pharmaceuticals Calls 11th AGM on Mangsir 26 to Approve Acquisition of Royal Pharmaceuticals
22nd November 2026, Kathmandu
Om Megashree Pharmaceuticals Limited has convened its 11th Annual General Meeting (AGM) for Mangsir 26, 2083 (December 12, 2026), following a decision made by the company’s Board of Directors on Mangsir 4, 2083.
Om Megashree 11th AGM Called
The primary agenda of the meeting is to endorse the acquisition of Royal Pharmaceuticals Limited alongside the approval of annual financial reports and the election of board directors.
Key Details of the 11th Annual General Meeting
The general meeting will take place at the company’s industrial premises in Chitwan, with a book closure date scheduled prior to the assembly.
- Convening Company: Om Megashree Pharmaceuticals Limited.
- Meeting Event: 11th Annual General Meeting (AGM).
- Board Decision Date: Mangsir 4, 2083 (November 20, 2026).
- AGM Date and Time: Mangsir 26, 2083 (December 12, 2026), starting at 9:15 AM.
- Venue: Company Industry Premises, Jugedi, Bharatpur Metropolitan City-29, Chitwan.
- Book Closure Date: Mangsir 15, 2083 (December 1, 2026).
- Shareholder Eligibility Cutoff: Shareholders maintaining ownership through NEPSE transactions up to Mangsir 14, 2083 (November 30, 2026) are eligible to attend the AGM and vote in board elections.
Special Agenda: Acquisition of Royal Pharmaceuticals Limited
The centerpiece of the general meeting is the formal corporate takeover of Royal Pharmaceuticals Limited, supported by an approved share swap structure.
- Target Entity: Royal Pharmaceuticals Limited.
- Approved Share Swap Ratio: 1 : 0.5744 (Shareholders of Royal Pharmaceuticals Limited will receive 0.5744 units of Om Megashree Pharmaceuticals shares for every 1 unit of Royal Pharmaceuticals share held).
- Acquisition Endorsements: Approval of the initial Memorandum of Understanding (MoU), subsequent amendments, formation of the acquisition committee, and the appointment of independent evaluators and legal advisors.
- Valuation and Final Agreement: Endorsement of the asset, liability, and business valuation report prepared by the independent evaluator, alongside the final acquisition agreement.
- Constitutional Amendments: Proposal to amend necessary provisions of the company’s Memorandum of Association (MoA) and Articles of Association (AoA) to facilitate the acquisition and post-merger corporate structure.
- Regulatory Authorization: Granting authority to the Board of Directors to execute further modifications or adjustments as directed by regulatory bodies or government offices during implementation.
Ordinary Agendas and Corporate Governance
In addition to the acquisition proposals, shareholders will review past fiscal performance and appoint governance representatives.
- Financial Statement Approval: Discussion and endorsement of the annual report for FY 2082/83, including the auditor’s report, balance sheet, profit and loss account, cash flow statement, and related schedules.
- Auditor Appointment: Appointment of the statutory auditor for the current fiscal year 2083/84 and determination of their remuneration.
- Board of Directors Election: Election of four directors representing the promoter shareholder group.
For More: Om Megashree 11th AGM Called





